Metabogenix Technologies, Inc., is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors as novel treatments for patients living with cancer.

Metabogenix has devised technologies using analogs of sugar in combination with other chemoagents to target these slow-growing tumor cell populations.

Metabogenix's team is comprised of experienced research scientists and business professionals with successful track records in the biotech industry.

(body)